Cipla trades higher on the bourses

25 Jul 2014 Evaluate

Cipla is currently trading at Rs. 442.80, up by 3.50 points or 0.80% from its previous closing of Rs. 439.30 on the BSE.

The scrip opened at Rs. 440.00 and has touched a high and low of Rs. 445.95 and Rs. 439.30 respectively. So far 60444 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 460.45 on 08-Jul-2014 and a 52 week low of Rs. 366.70 on 24-Feb-2014.

Last one week high and low of the scrip stood at Rs. 447.20 and Rs. 436.10 respectively. The current market cap of the company is Rs. 35597.52 crore.

The promoters holding in the company stood at 36.80% while Institutions and Non-Institutions held 35.85% and 26.23% respectively.

Cipla’s wholly owned subsidiary Meditab Specialities (MSPL) has acquired 75% stake in Mabpharm. The company was earlier holding 25% stake in Mabpharm. Consequent to the acquisition of the aforesaid stake, Mabpharm has now become 100% subsidiary of the company.

Mabpharm is inter alia engaged in development of monoclonal anitbodies for treatment of cancer and auto-immune diseases. While, Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. For more than 70 years, Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 170 countries.

Cipla Share Price

1502.25 -2.80 (-0.19%)
29-Dec-2025 11:16 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1721.90
Dr. Reddys Lab 1263.45
Cipla 1502.25
Zydus Lifesciences 905.45
Lupin 2093.40
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×